DrugBank Brings Grounded Biopharma Intelligence to Microsoft Copilot

New plugin connects DrugBank's deterministic Knowledge Graph to Microsoft Copilot, giving
biopharma R&D teams defensible, traceable answers inside the tools they already use

EDMONTON, AB, Sept. 28, 2026 /PRNewswire/ -- DrugBank, the AI-native knowledge engine for biopharma, today announced a collaboration with Microsoft to bring the DrugBank Knowledge Graph to Microsoft Copilot as a plugin. The integration gives biopharma R&D, strategy, and portfolio teams direct access to DrugBank's deterministic, fully traceable data: more than 150 million structured data points and billions of relationships spanning drugs, targets, diseases, and trials, from within Copilot experiences, including Copilot Chat, Researcher in Copilot, Microsoft Word, Microsoft Excel, Microsoft PowerPoint, Copilot agents, and Copilot Studio.

The collaboration aligns with a unified effort toward plugin-based Copilot architecture, through which connectors, agents, and skills become available across the full Copilot ecosystem. For biopharma customers, the DrugBank plugin grounds Copilot's reasoning in a knowledge graph built from 20 years of continuous curation, giving teams answers they can act on with confidence and cite directly.

"Biopharma teams have poured billions into AI over the past few years, and what determines whether that investment pays off is the data underneath it," said Lisa Downey, CEO of DrugBank. "Bringing DrugBank into Microsoft Copilot puts two decades of curated, deterministic knowledge directly into the tools our customers already use every day. Every answer is grounded, traceable, and repeatable: the same question returns the same answer every time, because it's retrieved from our graph, not reconstructed from scratch. That's what turns an AI answer into something a scientist can stand behind."

"Microsoft Copilot is most valuable when it's grounded in the knowledge that matters most to a customer's work," said Chantrelle Nielsen, Principal PM Manager, Microsoft. "DrugBank brings curated, trustworthy biopharma data into Copilot, giving our mutual customers a faster path from a question to a defensible answer, right inside the tools they already use."

For biopharma R&D teams, the DrugBank plugin is designed to speed up work across some of the highest-friction points in the drug discovery pipeline: target identification and prioritization, competitive and pipeline landscaping, mechanism-of-action and safety plausibility checks, and portfolio and business development evaluation. Instead of reconciling data by hand across siloed platforms, teams can ask Copilot a question and get an answer sourced directly from DrugBank's graph: deterministic, cited, and reproducible, without leaving their existing workflow.

DrugBank's Knowledge Graph connects scientific and commercial pharma data, including every drug approved by the FDA, EMA, and Health Canada, every active and historical clinical trial since 2020, and clinical-stage assets industry-wide, into a single, deeply connected structure mapped to more than 20 industry ontologies. Every result traces back to its source and is versioned, so findings hold up to scrutiny from a scientific team, an executive, or a regulator. DrugBank is the most cited biopharma intelligence resource, with more than 65,000 academic citations, and is used by 10 of the top 20 global pharmaceutical companies.

DrugBank's Knowledge Graph plugin is now available on Microsoft Marketplace.

About DrugBank
DrugBank is the AI-native knowledge engine for biopharma. We connect scientific and commercial data into a deterministic, deeply connected graph that plugs into the tools R&D, strategy, and portfolio teams are already using. Built from decades of continuous curation, we give biopharma teams a ready-to-use foundation to evaluate targets and assets, so they can make decisions with fewer blind spots. Learn more at DrugBank.com and follow us on LinkedIn.

SOURCE DrugBank